In the early 1900s, Carrel devised the "triangulation" technique that kept the vessel’s circular shape while stitching. Because the join did not narrow, surgeons could safely restore blood flow after cuts or injuries. By transplanting organs such as kidneys and hearts in animals, he also observed how long they survived and noticed the immune rejection phenomenon. These advances led directly to progress in battlefield surgery and emergency medicine, underpinning modern practices like blood transfusion and bypass operations. On a societal level, survival after traffic accidents or major surgery increased because of his work.

Carrel’s work laid the groundwork for machine-assisted anastomosis and microsurgery. In his triangulation method, three equidistant sutures were placed through each vessel end; by pulling the threads, the intima did not invert, lowering thrombosis risk. Using auto-, allo-, and xenograft models, he charted survival times and hinted that the immune system governed graft success. These observations foreshadowed the future development of immunosuppressants (e.g., cyclosporine) and organ-preservation solutions, steering the course of transplant surgery research. Modern bioengineered vascular grafts still rely on principles derived from Carrel’s suturing approach.

Carrel refined end-to-end vascular anastomosis employing triangulation, ensuring geometrical congruence and minimal intimal trauma; this innovation dramatically decreased peri-anastomotic thrombogenesis. He extended the method to end-to-side configurations, enabling arterial grafts and portocaval shunts. In organ transplantation, his canine/kidney xenograft series quantified ischemia tolerance and delineated hyperacute versus delayed rejection phases decades before the immunological mechanisms were elucidated. His collaboration with Charles Lindbergh on the pulsatile perfusion pump presaged ex vivo organ preservation systems. Collectively, these studies constitute the conceptual substrate for contemporary microsurgical revascularization, composite tissue allotransplantation, and tissue-engineered constructs.